MyFinsight
Home
Blog
About
Contact
Download
Download image
Net increase
(decrease) in cash, cash...
-$6,679,967
Stock-based compensation
$1,988,105
Accounts payable and
accrued expenses
$311,085
Depreciation of property and
equipment
$287,961
Grants receivable
-$219,923
Non-cash lease expense
$53,367
Deferred grant
reimbursement
$19,699
Net cash (used in)
operating activities
-$6,502,040
Net cash (used in)
investing activities
-$150,218
Net cash provided by
(used in) financing...
-$27,709
Canceled cashflow
$2,860,441
Canceled cashflow
$19,699
Net loss
-$9,158,734
Purchases of property and
equipment
$169,917
Payments on finance lease
obligations
$27,709
Tax receivable
$105,205
Amortization of deferred
grant reimbursement
-$52,913
Due to related party
-$26,533
Prepaid expenses and
other current assets
$19,096
Back
Back
Cash Flow
source: myfinsight.com
EXOZYMES INC. (EXOZ)
EXOZYMES INC. (EXOZ)